跳至主要内容
临床试验/NCT05689697
NCT05689697尚未招募不适用

Efficacy of Physiological Ketosis Induced by Liquid Technology Formula PanTrek in Asthenia and\or Decreased Tolerance to Physical and\or Mental Exertion (Double-blind, Placebo-controlled Study)

Ketonic Pharm LLC2 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2023年1月9日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
88
试验地点
2
主要终点
Primary outcome

研究概览

简要总结

The purpose of this study is evaluating of efficacy of innovative dietary strategy -stimulation of physiological ketosis with Liquid Technology Formula PanTrek, in patients with asthenia and or decreased tolerance to physical and\or mental exertion. PanTrek is a liquid formula of potassium and magnesium salts of beta-oxibutiric acid, ginsenosides and rosmarinic acid.

详细描述

It will be double-blind, placebo-controlled study in 88 patients of both sex, aged from 18 to 65. Patients will be randomly assigned to one of two groups: placebo or IP group in 1:1 proportion. Study instruments: D-Fis, MoCA, TMT, VAS, assessment of blood keton concentration before and after first and last administration per os of 25 ml of placebo or PanTrek. PanTrek will be served in ampuls, 25 ml per ampule.

The duration of the study will be 15 days of treatment and 15 days of follow-up observation.

Patients will be assessed at screening/baseline, after 15 days and after 30 days.

The dose regimen: the shot of PanTrek, 25 ml, will be administered per os, twice per day, in the morning and in the evening, per se or deluted in 100 ml of water one hour before or after meal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

randomized asignment to placebo or IP group, double-blind design

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • informed consent
  • diagnosis of astenia and/or decreased tolerance to physical and\or mental exertion
  • ability of patients to understand assessment procedures

排除标准

  • intollerance of components of PanTrek
  • participation in other trials

结局指标

主要结局

Primary outcome

时间窗: 15 days

Difference of changes of visual analog scale (VAS) indices between active treament and placebo groups. Minimum value - 0, maximum value - 100 scores. The higher score means the better condition. The major difference means better outcome.

次要结局

  • indused ketosis(15 days)

研究者

发起方
Ketonic Pharm LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验